arrow
T

Tobias Moll

University of Sheffield
H指数:12
被引数:724

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Paraspeckle condensation is controlled via TDP-43 polymerization and linked to neuroprotection

通过TDP-43聚合控制Paraspeckle缩合并与神经保护有关

2026-03-180
OAAI
Hypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosis

无假设评估循环代谢组提供了关于能量底物可及性在肌萎缩侧索硬化症中作用的细胞特异性见解

2026-03-060
OAAI
An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2

与ATXN2的CAG重复扩增相关的肌萎缩侧索硬化的多效性和渗透性的观察研究

2025-02-160
OAAI
Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis

线粒体功能的罕见和常见遗传决定因素决定了肌萎缩侧索硬化的严重程度,但没有风险

HELIYON
IF3.6
2024-02-013
OAAI
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication

EXOSC2的低表达可防止临床新型冠状病毒肺炎并阻止SARS-CoV-2复制

2022-10-141
OAAI
Atypical TDP-43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBP

在TARDBP中携带p.Y374X截短突变的ALS系谱中的非典型TDP-43蛋白表达

2022-07-246
OAAI
Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis
2022-03-178
OAAI
Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis
NEURON
IF15
2022-03-0162
OA
A review of Mendelian randomization in amyotrophic lateral sclerosis

肌萎缩侧索硬化症的孟德尔随机化综述

BRAIN
IF11.7
2021-11-1644
OA
Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene (vol 33, 108456, 2020)
2021-02-019
OAAI
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene
2020-12-0119
OAAI
Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis
2019-02-0161
OAAI